Defilade Capital Management »

Crinetics Pharmaceuticals In shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.0M 239k 37.42

More positions owned by Defilade Capital Management

Eli Lilly & Co. (LLY)
Pfizer (PFE)
Veeva Sys Cl A Com (VEEV)
BioMarin Pharmaceutical (BMRN)
Ptc Therapeutics I (PTCT)
Baxter International (BAX)
Insmed Com Par $.01 (INSM)
Zimmer Holdings (ZBH)
Insulet Corporation (PODD)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Ascendis Pharma A/s Ord Shs (ASND)
Solventum Corp Com Shs (SOLV)
Medtronic SHS (MDT)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Crinetics Pharmaceuticals In

FMR
BlackRock
Farallon Capital Management
Wellington Management Company
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Portfolio Management
Vanguard Capital Management
Jupiter Topco
Henderson Group
Geode Capital Management
Bellevue Group
State Street Corporation
Baker Bros. Advisors
Polar Capital Holdings

View all funds holding Crinetics Pharmaceuticals In